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Abstract The role of protein kinase C activation and carboxyl-
terminal region in rapid desensitization of the vasopressin Via 
receptor was investigated in Xenopus oocytes. Preincubation of 
the oocytes with vasopressin or with the diacylglycerol analog 
l-oleoyl-2-acetyl-sn-glycerol (OAG), or direct injection of active 
protein kinase C, all blunted the calcium response of the Via 
receptor. Truncation of the 51 terminal amino acids 
(S374STOP) modified neither the intracellular calcium response 
to vasopressin nor its desensitization by vasopressin or OAG. 
These data suggest that desensitization of the Via receptor is 
mediated by PKC activation and that its carboxyl-terminal 
domain is not required for signal transduction and rapid 
desensitization. 
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1. Introduction 
Vasopressin Via receptor is widely distributed in several 
tissues such as blood vessels, kidney, choroid plexus, liver or 
central nervous system [1]. It belongs to the superfamily of the 
G-protein-coupled receptors with seven transmembrane do-
mains. Binding of vasopressin (AVP) to the Via receptor acti-
vates phospholipase C and produces inositol tri-phosphate and 
diacylglycerol, which respectively increase intracellular calcium 
and activate protein kinase C (PKC). Like most G-protein-
coupled receptors already studied [2], the Via receptor under-
goes desensitization when stimulated by its agonist. This ho-
mologous desensitization is characterized by the inability of 
the receptor to induce a further intracellular response when 
it is successively challenged by vasopressin. Such rapid desen-
sitization is probably linked to uncoupling of the receptor 
from G proteins within seconds, whereas internalization would 
occur within minutes. Both rapid desensitization and internal-
ization have been demonstrated for the Via receptor in native 
tissue and in cells expressing the cloned receptor [3-6]. 
The most frequently invoked mechanism for rapid desensi-
tization refers to phosphorylation of threonine and serine res-
idues by protein kinase A or C and/or by G receptor kinase 
[7]. This phosphorylation may be consecutive to binding of 
the ligand to the receptor or to activation of protein kinase by 
second messengers [7-11]. The role of protein kinase A acti-
vation by cAMP on desensitization has been well demon-
strated for adenylyl cyclase coupled receptor. On the other 
hand, the effect of protein kinase C activation by diacylglyc-
erol on the desensitization process is less documented. 
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The Via receptor, like other transmembrane G protein re-
ceptors, has a number of threonine and serine residues which 
are putative sites for phosphorylation and may be involved in 
desensitization. These residues are located either on the intra-
cellular loops or on the intracellular C-terminal tail of the 
receptor. Current experiments on adenylyl cyclase coupled 
receptors with a C-terminal tail which has been truncated or 
mutated indicate that phosphorylation of carboxyl-terminal 
residues is implicated in rapid desensitization [7]. Data on 
the role of C-terminal tail in phospholipase C coupled recep-
tors are more conflicting. Carboxyl terminus truncation of the 
alpha-lb adrenergic receptor, for example, impairs agonist-
dependent desensitization [12]. In contrast, experiments with 
angiotensin AT la receptor brought evidence for a role of the 
carboxyl-terminal residues in the mechanisms of rapid desen-
sitization [9], whereas other experiments did not [10]. It is in 
this respect that the roles of C-terminal tail and protein kinase 
C activation in desensitization of the Via receptor was further 
investigated in this study. 
2. Materials and methods 
2.1. Construction of the mutant receptor cDNAs and expression vectors 
Using the cloned rat Via receptor [13,14], three different mutant 
stops were constructed by the Altered Site II in vitro mutagenesis 
System (Promega) as described by the manufacturer. Mutant oligonu-
cleotides were as follows: S374STOP, 5'-CCATGCTGCACT-
GAATGG CGCAGAAATTCGCC-3', Q367STOP, 5'-GCAAGACT-
GCGTTCTAAAGTTTCCCATG CTGC-3', H360STOP, 5'-TAC-
ATGTTTTTCAG TGGCTAACTCCTGCAAGAC-3'. The first mu-
tant was truncated at serine-374 (Fig. 1) of the carboxyl-terminal 
region of the receptor (S374STOP). This truncation removed the 51 
last amino acids of the C-terminal tail. The second one was truncated 
at glutamine-367 (Q367STOP) and lacked the 58 C-terminal amino 
acids. The third one was truncated at histidine-360 (H360STOP) and 
lacked the 65 C-terminal amino acids. 
In a second series, a stretch of nucleotides coding for a 9-amino 
acid epitope (TagHA) derived from the influenza virus hemagglutinin 
protein (YPYDVPDYA) was introduced in the three resulting cDNA 
and the wild type at their N-terminus Cspl restriction site [15]. This 
modification in the structure of the receptors did not alter the calcium 
response induced by vasopressin when expressed in oocytes (data not 
shown). All cDNA were sequenced before expression. 
2.2. Oocyte expression and intracellular calcium detection by 
photoprotein aequorin 
Female albino oocyte-positive Xenopus laevis were purchased from 
Xenopus One (Ann Arbor, MI, USA). Synthetic messenger RNA 
(cRNA) corresponding to the rat vasopressin Via receptor (wild 
type or mutant) [13,14] was produced by in vitro transcription [16] 
using the mCAP mRNA Capping Kit from Stratagene. Two days 
after injection of the synthesized messenger cRNA (30 nl at 0.1 mg/ 
ml) in defolliculated oocytes, the photoprotein aequorin (Friday Har-
bour Laboratory, USA) was injected (20 nl at 1 mg/ml). Changes in 
the intracellular calcium concentration following addition of vasopres-
sin were detected by light emission [17] using a luminometer (Mini-
Lumat LB9506, Berthold). Results were expressed as relative units of 
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light emission (RLU). It corresponded to the percentage of the max-
imal response obtained on the day of the assays. Experiments were 
performed in a buffer solution (OR2) containing 82.5 mM NaCl, 
2.5 mM KC1, 1 mM MgCl2, 1 mM CaCl2, 1 mM Na2HP04, 5 mM 
HEPES, 0.1% bovine serum albumin, pH 7.8. Each set of conditions 
was tested at least in five oocytes per animal and in three different 
animals. Means are given ± S.E.M. with n corresponding to the num-
ber of experiments. 
2.3. Injection of purified protein kinase C 
Thirty nl of 10 ng/ml (820 U/mg) catalytic fragment of protein 
kinase C from rat brain (Biomol, USA) were injected in expressing 
oocytes. Ten minutes after injection, oocytes were challenged with 
10~7 M vasopressin and intracellular calcium mobilization was re-
corded. 
2.4. Assay of desensitization by AVP 
Receptors expressing oocytes were incubated for 2 min in OR2 
buffer containing 0.1% BSA and 10~7 M AVP, then extensively 
washed with OR2 medium. 15 min later, a second challenge was 
made with 10-7 M AVP and light emission was monitored. 
2.5. Assay of desensitization by OAG 
Expressing oocytes were incubated in 50 |iM of the diacylglycerol 
l-oleoyl-2-acetyl-sn-glycerol (OAG) [18] (Calbiochem) for 10 min and 
then challenged with 10~7 M vasopressin. 
2.6. Immunohistochemistry 
Oocytes expressing TagHA receptors were equilibrated in OR2 30%o 
saccharose, fixed in 4% paraformaldehyde in 0.1 M phosphate buffer 
(pH 7.4), frozen on dry ice and cut into 10 urn thick sections. The 
sections were equilibrated with phosphate buffer saline (PBS) and 
treated with 3% BSA, 0.1%o (v/v) Tween20 for 1 h at room temper-
ature, then washed and incubated for 30 min with 25 |Xg/ml anti-HA 
(12CA5) monoclonal antiserum at room temperature in the blocking 
buffer. Sections were subsequently washed with PBS and incubated 
for 30 min with rhodamine-conjugated goat anti-mouse IgG (Pierce 
Chemicals) at a 1:160 dilution. After washing in PBS, the sections 
were mounted in 80%. glycerol, 20% PBS and examined with an in-
verted microscope equipped with fluorescence optics. 
3. Results and discussion 
The addition of vasopressin to oocytes which had been 
previously injected with the full-length Via cRNA receptor 
induced a rapid spike in intracellular calcium within seconds 
. _ _ ^ , 
Fig. 1. Schematic representation of the carboxyl-terminal tail of the 
rat vasopressin Via receptor. S corresponded to serine residue, T to 
threonine, C to cysteine, H to histidine and Q to glutamine. The 
three mutated receptors were truncated on position 360 
(H360STOP), 367 (Q367STOP) and 374 (S374STOP), as indicated. 
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Fig. 2. Effect of PKC activation on Via receptor expressed in Xeno-
pus oocytes. Oocytes were injected with cRNA of the cloned Via 
vasopressin receptor. Three days later they were stimulated with 
AVP, and intracellular calcium was detected by aequorin. (o) Con-
trol. ( A ) 0.3 ng catalytic fragment of human protein kinase C was 
injected 10 min before AVP stimulation. (■) Oocytes were preincu-
bated in 50 u.M of the diacylglycerol analog OAG for 10 min. (•) 
Oocytes were incubated for 2 min in 10~7 M AVP and then exten-
sively washed before new stimulation. Mean of 3 different experi-
ments. 
following addition of the hormone (Fig. 2). This increase in 
intracellular calcium was transient. It reached a maximum in 
12 s and returned to a plateau in 120 s. Addition of vaso-
pressin to control oocytes which were injected with cRNA 
vehicle did not elicit any change in intracellular calcium. 
Rapid desensitization of the Via receptor was evidenced by 
successive stimulations. Addition of 10~7 M vasopressin to 
Vla-expressing oocyte for 2 min was followed by extensive 
wash of the incubation medium. A second challenge with 
vasopressin 15 min later failed to elicit a calcium spike (Fig. 
2). This rapid desensitization of the Via receptor is in good 
agreement with the data of Nathanson et al. in oocytes and of 
Cantau et al., Caramelo et al. and Grier et al. in liver or 
vascular cells [3-6]. The loss of vasopressin responsiveness 
of the oocyte was not attributable to impaired activity of 
the cell, since a second calcium spike could be induced by 
vasopressin 1 h after the first stimulation. This delay can be 
considered as the time necessary for full resensitization of the 
oocytes expressing the Via receptor. 
To test whether the observed desensitization involves the 
Via receptor or its associated transduction pathways, G pro-
tein was directly activated by injection of the GTP analog 
GTP'yS (20 pg) 10 min after AVP stimulation. In these con-
ditions, GTPyS injection still induced an increase in intracel-
lular calcium concentration (data not shown). This result sug-
gests that desensitization, in these conditions, is essentially 
specific for the receptor. 
The involvement of protein kinase C activation in desensi-
tization of the Via receptor was further investigated. The 
Vla-expressing oocytes were incubated for 10 min with 
50 (iM of the diacyl glycerol analog l-oleyl-2-acetyl-sn-glycer-
ol (OAG) [18]. As shown in Fig. 2, OAG attenuated the vaso-
pressin-induced calcium peak by 80%. The role of PKC in this 
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Fig. 3. AVP-dependent intracellular calcium signallisation of full 
length and truncated Via receptors. Oocytes were injected with 
cRNA of full length Via receptor (o), or receptor which C-terminal 
tail was truncated at serine-374 (□) or glutamine-367 ( A ) or histi-
dine-360 (A) . Three days later they were stimulated with AVP, and 
intracellular calcium was detected by aequorin. Mean of 3 different 
experiments. 
desensitization of the Via receptor was subsequently ad-
dressed by direct injection within the oocyte of the catalytic 
fragment of the PKC. Increasing intracellular PKC activity 
through such a procedure blunted the response to vasopressin 
in Vla-expressing oocytes (Fig. 2). These experiments indicate 
that the activation of PKC by diacylglycerol following occu-
pation of the Via receptor by vasopressin contributes to its 
rapid desensitization. 
The consequence of protein kinase C activation would be 
an increased phosphorylation of intracellular proteins. Among 
proteins which are putative targets for phosphorylation is the 
receptor itself, as evidenced for the vasopressin V2 receptor 
[8]. Although not yet demonstrated, it could be hypothesized 
that the parent Via receptor is also a target for phosphoryl-
ation. In this respect, one may question which phosphorylated 
site of the receptor should be responsible for desensitization. 
A predominant role for phosphorylation of the intracellular 
C-terminal tail has been frequently invoked in these mecha-
nisms of desensitization [8-12]. The strongest experimental 
evidence for such a role of the C-terminal tail is the lack of 
rapid desensitization of receptors which C-terminal tail is 
truncated [7,9,12,20]. The predominant role of the C-terminal 
region is also supported by the absence of rapid desensitiza-
tion of receptors lacking the intracytoplasmic C-terminal 
domain, such as the gonadotropin-releasing hormone receptor 
[19]. However, other experiments indicated that the carboxyl-
Fig. 4. Immunofluorescent localization of wild-type and carboxy-terminal truncated Via receptor. Oocytes expressing epitope-tagged wild-type 
Via receptor (Tag-Vla) or receptor which C-terminal tail was truncated at serine-374 (Tag-S374STOP), glutamine-367 (Tag-Q367STOP) or his-
tidine-360 (Tag-H360STOP) was treated as described in Section 2. Controls was oocytes expressing non-tagged Via receptor treated in same 
condition. 
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Fig. 5. Desensitization of the Via receptor truncated on serine-374 
(S374STOP). Oocytes were injected with cRNA of the mutated 
S374STOP vasopressin receptor. Three days later they were stimu-
lated with AVP, and intracellular calcium was detected by aequorin. 
(□) Control, ( A ) Oocytes were preincubated in 50 uM of the cell 
permeable diacylglycerol analog OAG for 10 min. (•) Oocytes were 
incubated for 2 min in 10~7 M AVP and then extensively washed 
before new stimulation. Mean of 3 different experiments. 
terminal region is not the only site of phosphorylation respon-
sible for acute desensitization. Truncation of the terminal do-
main of the endothelin A receptor [20], for example, did not 
affect its rapid desensitization nor the agonist-dependent in-
tracellular increase in calcium concentration. 
In the present experiment, the contribution of the C-termi-
nal domain of the Via receptor to the diacyl glycerol-induced 
desensitization was investigated with different mutants. The 
first mutant (H360STOP) was truncated at histidine-360, 
which removed the last 65 C-terminal amino acids (Fig. 1). 
When expressed in oocytes, this H360STOP mutant did not 
elicit calcium response to vasopressin (Fig. 3). Oocytes ex-
pressing Q367STOP which lack the 58 C-terminal amino acids 
showed a small but significant intracellular calcium response 
after agonist stimulation. In contrast, stimulation of the 
S374STOP expressing oocyte with AVP elicited a calcium re-
sponse which was comparable to that observed with the full-
length Via receptor (Fig. 3). 
The differences in calcium response of the three mutants 
may be due to change in signalling capacity of the truncated 
receptors or to their expression at the membrane of the cell. 
The presence of the mutant receptors on the surface of the 
oocytes was evidenced by immunochemistry using epitope-
tagged HA receptor. Comparable fluorescent signals at the 
surface of the oocytes were found for the epitope-tagged 
wild type and the three truncated receptors (Fig. 4). It indi-
cates that all the tested receptors were well expressed at the 
cell surface. The difference in their calcium response to AVP is 
therefore likely attributable to the truncated 6 and 11 amino 
acids including the two adjoining cysteines in positions 372 
and 371, and the single cysteine in position 365. 
Desensitization of the functional S374STOP mutant deleted 
with the last 51 terminal amino acids was compared to that of 
the Via wild type. This receptor retained the two cysteines 
residues in positions 371 and 372 which are suspected to be 
involved in the palmitoylation of the receptor and its anchor-
age to the membrane [21]. The AVP induced homologous 
desensitization performed on this truncated mutant was not 
different from that of the wild-type receptor (Fig. 5). Preincu-
bation with OAG of the oocytes expressing the S374STOP 
mutant nearly abolished the calcium response to vasopressin, 
similarly to the full-length Via receptor (Fig. 5). It indicates 
that the last 51 terminal amino acids are not necessary for 
acute desensitization of the Via receptor. 
In conclusion, Via receptor undergoes rapid desensitization 
which can be mimicked by diacylglycerol analog and in-
creased PKC activity. This desensitization is observed with 
truncated receptor which lacks most of its carboxyl-terminal 
domain, but which intracellular signalling was comparable to 
that of the wild-type receptor. It indicates that the C-terminal 
tail is not required for signal transduction and rapid desensi-
tization of Via receptor. 
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